SCHEMBL429917

SCHEMBL429917

Cc1ccc(-c2cc(C)c(C3C(=O)CC(=Cc4ccccn4)C3=O)c(C)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.43
▸ NPC1 O15118 4/20 0.43
▸ RAB9A P51151 4/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ XBP1 P17861 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ MAPK1 P28482 5/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ IKBKB O14920 5/20 0.41
▸ PRKAG1 P54619 5/20 0.41
▸ PRKAA1 Q13131 5/20 0.41
▸ NEK1 Q96PY6 5/20 0.41
▸ PRKAB1 Q9Y478 5/20 0.41
▸ RAF1 P04049 3/20 0.41
▸ RPS6KB1 P23443 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL427527 0.93 NPC1 (0.45) MAPTNPC1RAB9ASMN1; SMN2XBP1
SCHEMBL428716 0.91 NPC1 (0.42) MAPTNPC1RAB9ASMN1; SMN2XBP1
SCHEMBL430381 0.90 MAPT (0.48) MAPTNPC1RAB9ASMN1; SMN2XBP1
SCHEMBL464644 0.90 MAPT (0.48) MAPTNPC1RAB9ASMN1; SMN2XBP1
SCHEMBL428616 0.85 MAPT (0.46) MAPTNPC1RAB9ASMN1; SMN2XBP1
SCHEMBL429897 0.85 MAPT (0.46) MAPTNPC1RAB9ASMN1; SMN2XBP1
SCHEMBL429900 0.85 NPC1 (0.46) MAPTNPC1RAB9ASMN1; SMN2XBP1
SCHEMBL11963688 0.79 MAPT (0.40) MAPTNPC1RAB9ASMN1; SMN2XBP1
SCHEMBL428660 0.78 NPC1 (0.34) MAPTNPC1RAB9ASMN1; SMN2XBP1
SCHEMBL430762 0.75 NPC1 (0.32) MAPTNPC1RAB9ASMN1; SMN2XBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997824-A1 NOVEL HERBICIDES Syngenta Participations AG. (CH) 2016-03-23 — — EP disclosed
EP-2375898-B1 NOVEL HERBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2015-09-16 — — EP disclosed
US-8889595-B2 Herbicides SYNGENTA PARTICIPATIONS AG (CH) 2014-11-18 — — US disclosed
US-8889595-B2 Herbicides SYNGENTA PARTICIPATIONS AG (CH) 2014-11-18 — — US disclosed
US-20120065064-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-03-15 — — US disclosed
WO-2010069834-A1 NOVEL HERBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2010-06-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065064-A1 NOVEL HERBICIDES DDT, CYP1B1, CYP4X1 MAPT 3792/4885NPC1 4593/4885RAB9A 3219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback